SMALL CELL; RECEPTORS

Clinical trials for SMALL CELL; RECEPTORS explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL; RECEPTORS trials appear

Sign up with your email to follow new studies for SMALL CELL; RECEPTORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Your genes could dictate your cancer drug dose

Disease control Recruiting now

This study is testing whether adjusting the dose of a cancer drug (belinostat) based on a patient's specific genetics can make treatment safer and more effective. It is for adults with aggressive neuroendocrine cancers. Participants receive a combination of three drugs, with the …

Matched conditions: SMALL CELL; RECEPTORS

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

SMALL CELL; RECEPTORS

Get alerted when new SMALL CELL; RECEPTORS trials appear

Your genes could dictate your cancer drug dose